Potential role of blood biomarkers in the management of nontraumatic intracerebral hemorrhage

Cerebrovascular Diseases

Volumn 38, Issue 6, 2014, Pages 395-409

  Senn, Rebecca ^a   Elkind, Mitchell S V ^c   Montaner, Joan ^b   Christ Crain, Mirjam ^a   Katan, Mira ^d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Department of Neurology Val d'Hebron ^*  (Spain)

^c Departments of Neurology and Epidemiology Columbia University ^*  (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Blood biomarker; Intracerebral hemorrhage; Management; Stroke

Indexed keywords

AMYLOID BETA PROTEIN; ANGIOPOIETIN 1; APOLIPOPROTEIN C3; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 13; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; COPEPTIN; D DIMER; FERRITIN; FIBRINOGEN; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUTAMIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; PROTEIN S100B; SOLUBLE FAS PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1; VASCULOTROPIN; CYTOKINE; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; GLYCOPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; S100B PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR ANTIGEN;

BRAIN DAMAGE; BRAIN HEMORRHAGE; DISEASE MARKER; FUNCTIONAL STATUS; GLUCOSE BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; BLOOD; CEREBRAL HEMORRHAGE;

AMYLOID BETA-PEPTIDES; ANTIGENS, NEOPLASM; APOLIPOPROTEIN C-III; BIOLOGICAL MARKERS; CEREBRAL HEMORRHAGE; CYTOKINES; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPEPTIDES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PROGNOSIS; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84917729765     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000366470     Document Type: Review

References (91)

1. Mukherjee D, Patil CG: Epidemiology and the global burden of stroke. World Neurosurg 2011; 76:S85-S90.
2. Grysiewicz RA, Thomas K, Pandey DK: Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin 2008; 26: 871-895, vii.
3. Agnihotri S, Czap A, Staff I, Fortunato G, McCullough LD: Peripheral leukocyte counts and outcomes after intracerebral hemorrhage. J Neuroinflammation 2011; 8: 160.
4. Flaherty ML, Haverbusch M, Sekar P, Kissela B, Kleindorfer D, Moomaw CJ, Sauerbeck L, Schneider A, Broderick JP, Woo D: Longterm mortality after intracerebral hemorrhage. Neurology 2006; 66: 1182-1186.
5. Manno EM: Update on intracerebral hemorrhage. Continuum (Minneap Minn) 2012; 18: 598-610.
6. Lovelock CE, Molyneux AJ, Rothwell PM: Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 2007; 6: 487-493.
7. Lovelock CE, Cordonnier C, Naka H, Al-Shahi Salman R, Sudlow CL, Sorimachi T, Werring DJ, Gregoire SM, Imaizumi T, Lee SH, Briley D, Rothwell PM: Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke 2010; 41: 1222-1228.
8. Thanvi BR, Sprigg N, Munshi SK: Advances in spontaneous intracerebral haemorrhage. Int J Clin Pract 2012; 66: 556-564.
9. Keep RF, Hua Y, Xi G: Intracerebral haemorrhage: Mechanisms of injury and therapeutic targets. Lancet Neurol 2012; 11: 720-731.
10. Inaji M, Tomita H, Tone O, Tamaki M, Suzuki R, Ohno K: Chronological changes of perihematomal edema of human intracerebral hematoma. Acta Neurochir Suppl 2003; 86: 445-448.
11. Qureshi AI, Mendelow AD, Hanley DF: Intracerebral haemorrhage. Lancet 2009; 373: 1632-1644.
12. Olsson T, Marklund N, Gustafson Y, Nasman B: Abnormalities at different levels of the hypothalamic- pituitary-adrenocortical axis early after stroke. Stroke 1992; 23: 1573-1576.
13. Sharp F, Liu DZ, Zhan X, Ander BP: Intracerebral hemorrhage injury mechanisms: glutamate neurotoxicity, thrombin, and Src. Acta Neurochir Suppl 2008; 105: 43-46.
14. Xi G, Reiser G, Keep RF: The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem 2003; 84: 3-9.
15. Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT: Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg 2002; 96: 287-293.
16. Hua Y, Xi G, Keep RF, Hoff JT: Complement activation in the brain after experimental intracerebral hemorrhage. J Neurosurg 2000; 92: 1016-1022.
17. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC: The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32: 891-897.
18. Henley SM, Bates GP, Tabrizi SJ: Biomarkers for neurodegenerative diseases. Curr Opin Neurol 2005; 18: 698-705.
19. Rosell A, Vilalta A, Garcia-Berrocoso T, Fernandez-Cadenas I, Domingues-Montanari S, Cuadrado E, Delgado P, Ribo M, Martinez- Saez E, Ortega-Aznar A, Montaner J: Brain perihematoma genomic profile following spontaneous human intracerebral hemorrhage. PLoS One 2011; 6:e16750.
20. Kodali P, Jurkevica A, Landero J, Kuhlmann C, Caruso J, Adeoye O: Multiple liquid chromatography separations and nanoESI-ion trap detection of plasma proteins in search of stroke biomarkers: a pilot study. J Sep Sci 2012; 35: 2153-2161.
21. Gilstrap LG, Wang TJ: Biomarkers and cardiovascular risk assessment for primary prevention: an update. Clin Chem 2012; 58: 72-82.
22. Tuntiyatorn L, Saksornchai P, Tunlayadechanont S: Identification of stroke mimics among clinically diagnosed acute strokes. J Med Assoc Thai 2013; 96: 1191-1198.
23. Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, MacDonald RL, Messe SR, Mitchell PH, Selim M, Tamargo RJ: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41: 2108-2129.
24. Barber PA, Kleinig TJ: INTERACT2: a reason for optimism with spontaneous intracerebral hemorrhage? Int J Stroke 2014; 9: 59-60.
25. Bettermann K: Biomarkers for stroke: in search of fingerprints. J Stroke Cerebrovasc Dis 2011; 20: 173-176.
26. Adeoye O, Broderick JP: Advances in the management of intracerebral hemorrhage. Nat Rev Neurol 2010; 6: 593-601.
27. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC: Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 2001; 56: 1294-1299.
28. Zuccarello M, Brott T, Derex L, Kothari R, Sauerbeck L, Tew J, Van Loveren H, Yeh HS, Tomsick T, Pancioli A, Khoury J, Broderick J: Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke 1999; 30: 1833-1839.
29. Prasad V, Bonow RO: The cardiovascular biomarker conundrum: challenges and solutions. JAMA 2011; 306: 2151-2152.
30. Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenstrom H: Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem 1999; 45: 138-141.
31. Dvorak F, Haberer I, Sitzer M, Foerch C: Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc Dis 2009; 27: 37-41.
32. Foerch C, Niessner M, Back T, Bauerle M, De Marchis GM, Ferbert A, Grehl H, Hamann GF, Jacobs A, Kastrup A, Klimpe S, Palm F, Thomalla G, Worthmann H, Sitzer M: Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem 2012; 58: 237-245.
33. Yan SF, Naka Y, Hudson BI, Herold K, Yan SD, Ramasamy R, Schmidt AM: The ligand/ RAGE axis: lighting the fuse and igniting vascular stress. Curr Atheroscler Rep 2006; 8: 232-239.
34. Donato R: Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999; 1450: 191-231.
35. Montaner J, Mendioroz M, Delgado P, Garcia- Berrocoso T, Giralt D, Merino C, Ribo M, Rosell A, Penalba A, Fernandez-Cadenas I, Romero F, Molina C, Alvarez-Sabin J, Hernandez-Guillamon M: Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway. J Proteomics 2012; 75: 4758-4765.
36. Allard L, Lescuyer P, Burgess J, Leung KY, Ward M, Walter N, Burkhard PR, Corthals G, Hochstrasser DF, Sanchez JC: ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics 2004; 4: 2242-2251.
37. Yamada M: Cerebral amyloid angiopathy: an overview. Neuropathology 2000; 20: 8-22.
38. Hernandez-Guillamon M, Delgado P, Penalba A, Rodriguez-Luna D, Molina CA, Rovira A, Alvarez-Sabin J, Boada M, Montaner J: Plasma beta-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke. Neurodegener Dis 2012; 10: 320-323.
39. Yamada M: Brain hemorrhages in cerebral amyloid angiopathy. Semin Thromb Hemost 2013; 39: 955-962.
40. Greenberg SM, Cho HS, O'Donnell HC, Rosand J, Segal AZ, Younkin LH, Younkin SG, Rebeck GW: Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy. Ann N Y Acad Sci 2000; 903: 144-149.
41. Yong VW: Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 2005; 6: 931-944.
42. Cuadrado E, Rosell A, Penalba A, Slevin M, Alvarez-Sabin J, Ortega-Aznar A, Montaner J: Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 2009; 8: 3191-3197.
43. Parks WC, Wilson CL, Lopez-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4: 617-629.
44. Abilleira S, Montaner J, Molina CA, Monasterio J, Castillo J, Alvarez-Sabin J: Matrix metalloproteinase- 9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 2003; 99: 65-70.
45. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Davalos A: Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005; 36: 86-91.
46. Wang J, Tsirka SE: Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage. Neurocrit Care 2005; 3: 77-85.
47. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, et al: Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412.
48. Sviri GE, Soustiel JF, Zaaroor M: Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury. Acta Neurochir (Wein) 2006; 148: 529-533; discussion 533.
49. James ML, Blessing R, Phillips-Bute BG, Bennett E, Laskowitz DT: S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage. Biomarkers 2009; 14: 388-394.
50. Hernandez-Guillamon M, Sole M, Delgado P, Garcia-Bonilla L, Giralt D, Boada C, Penalba A, Garcia S, Flores A, Ribo M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J: VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke. Cerebrovasc Dis 2012; 33: 55-63.
51. Ma Q, Manaenko A, Khatibi NH, Chen W, Zhang JH, Tang J: Vascular adhesion protein- 1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice. J Cereb Blood Flow Metab 2011; 31: 881-893.
52. Cascino I, Fiucci G, Papoff G, Ruberti G: Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 1995; 154: 2706-2713.
53. Delgado P, Cuadrado E, Rosell A, Alvarez- Sabin J, Ortega-Aznar A, Hernandez-Guillamon M, Penalba A, Molina CA, Montaner J: Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage. Stroke 2008; 39: 1730-1734.
54. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH: Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 2001; 8: 679-686.
55. Ackery A, Robins S, Fehlings MG: Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J Neurotrauma 2006; 23: 604-616.
56. Kim SH, Smith CJ, Van Eldik LJ: Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol Aging 2004; 25: 431-439.
57. Ponath G, Schettler C, Kaestner F, Voigt B, Wentker D, Arolt V, Rothermundt M: Autocrine S100B effects on astrocytes are mediated via RAGE. J Neuroimmunol 2007; 184: 214-222.
58. Hu YY, Dong XQ, Yu WH, Zhang ZY: Change in plasma S100B level after acute spontaneous basal ganglia hemorrhage. Shock 2010; 33: 134-140.
59. Lee SH, Kim BJ, Bae HJ, Lee JS, Lee J, Park BJ, Yoon BW: Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study. Diabetologia 2010; 53: 429-434.
60. Vespa PM: Intensive glycemic control in traumatic brain injury: what is the ideal glucose range? Crit Care 2008; 12: 175.
61. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, Lee MH, Han PL, Park JS, Lee JK: HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006; 26: 6413-6421.
62. Fang HY, Ko WJ, Lin CY: Inducible heat shock protein 70, interleukin-18, and tumor necrosis factor alpha correlate with outcomes in spontaneous intracerebral hemorrhage. J Clin Neurosci 2007; 14: 435-441.
63. Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, Silva Y, Montaner J, Kase CS: Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 2002; 58: 624-629.
64. Wang KW, Cho CL, Chen HJ, Liang CL, Liliang PC, Tsai YD, Wang HK, Lu K: Molecular biomarker of inflammatory response is associated with rebleeding in spontaneous intracerebral hemorrhage. Eur Neurol 2011; 66: 322-327.
65. Fang HY, Ko WJ, Lin CY: Plasma interleukin 11 levels correlate with outcome of spontaneous intracerebral hemorrhage. Surg Neurol 2005; 64: 511-517, discussion 517-518.
66. Di Napoli M, Godoy DA, Campi V, del Valle M, Pinero G, Mirofsky M, Popa-Wagner A, Masotti L, Papa F, Rabinstein AA: C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score. Stroke 2011; 42: 1230-1236.
67. Zhou Y, Xiong KL, Lin S, Zhong Q, Lu FL, Liang H, Li JC, Wang JZ, Yang QW: Elevation of high-mobility group protein box-1 in serum correlates with severity of acute intracerebral hemorrhage. Mediators Inflamm 2010; pii:142458. DOI: 10.1155/2010/142458. Epub 2010 Sep 29.
68. Sobrino T, Arias S, Perez-Mato M, Agulla J, Brea D, Rodriguez-Yanez M, Castillo J: CD34+ progenitor cells likely are involved in the good functional recovery after intracerebral hemorrhage in humans. J Neurosci Res 2011; 89: 979-985.
69. Sobrino T, Arias S, Rodriguez-Gonzalez R, Brea D, Silva Y, de la Ossa NP, Agulla J, Blanco M, Pumar JM, Serena J, Davalos A, Castillo J: High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage. J Cereb Blood Flow Metab 2009; 29: 1968-1974.
70. Perez de la Ossa N, Sobrino T, Silva Y, Blanco M, Millan M, Gomis M, Agulla J, Araya P, Reverte S, Serena J, Davalos A: Iron-related brain damage in patients with intracerebral hemorrhage. Stroke 2010; 41: 810-813.
71. Rodriguez-Luna D, Rubiera M, Ribo M, Coscojuela P, Pagola J, Pineiro S, Ibarra B, Meler P, Maisterra O, Romero F, Alvarez-Sabin J, Molina CA: Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage. Stroke 2011; 42: 2447-2452.
72. Roquer J, Rodriguez Campello A, Gomis M, Ois A, Munteis E, Bohm P: Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology 2005; 65: 1198-1202.
73. Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Doi M, Izumi Y, Ohta H: Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation 2009; 119: 2136-2145.
74. Ramirez-Moreno JM, Casado-Naranjo I, Portilla JC, Calle ML, Tena D, Falcon A, Serrano A: Serum cholesterol LDL and 90-day mortality in patients with intracerebral hemorrhage. Stroke 2009; 40: 1917-1920.
75. Fujii Y, Takeuchi S, Harada A, Abe H, Sasaki O, Tanaka R: Hemostatic activation in spontaneous intracerebral hemorrhage. Stroke 2001; 32: 883-890.
76. Chiu CC, Li YN, Lin LJ, Hsiao CT, Hsiao KY, Chen IC: Serum D-dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhage. J Clin Neurosci 2012; 19: 810-813.
77. Leira R, Davalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, Castillo J: Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 2004; 63: 461-467.
78. Marti-Fabregas J, Borrell M, Silva Y, Delgado- Mederos R, Martinez-Ramirez S, de Juan- Delago M, Tirado I, Alejaldre A, Marin R, Marti-Vilalta JL, Fontcuberta J: Hemostatic proteins and their association with hematoma growth in patients with acute intracerebral hemorrhage. Stroke 2010; 41: 2976-2978.
79. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, Muller K, Meckel S, Gass A, Kappos L, Steck AJ, Engelter ST, Muller B, Christ-Crain M: Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 2009; 66: 799-808.
80. Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A, Mueller B, Christ-Crain M: Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol 2010; 10: 34.
81. Zhang X, Lu XM, Huang LF, Ye H: Copeptin is associated with one-year mortality and functional outcome in patients with acute spontaneous basal ganglia hemorrhage. Peptides 2012; 33: 336-341.
82. Kim JY, Yenari MA: The immune modulating properties of the heat shock proteins after brain injury. Anat Cell Biol 2013; 46: 1-7.
83. Nomura S, Ozaki Y, Ikeda Y: Function and role of microparticles in various clinical settings. Thromb Res 2008; 123: 8-23.
84. Ardoin SP, Shanahan JC, Pisetsky DS: The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007; 66: 159-165.
85. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS: Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006; 39: 683-690.
86. Dong XQ, Huang M, Hu YY, Yu WH, Zhang ZY: Time course of plasma microparticle concentrations after acute spontaneous basal ganglia hemorrhage. Acta Neurol Scand 2011; 123: 280-288.
87. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-785.
88. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358: 2127-2137.
89. Manaenko A, Fathali N, Khatibi NH, Lekic T, Hasegawa Y, Martin R, Tang J, Zhang JH: Arginine- vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury. Neurochem Int 2011; 58: 542-548.
90. Song S, Hua Y, Keep RF, Hoff JT, Xi G: A new hippocampal model for examining intracerebral hemorrhage-related neuronal death: effects of deferoxamine on hemoglobin-induced neuronal death. Stroke 2007; 38: 2861-2863.
91. James ML, Wang H, Venkatraman T, Song P, Lascola CD, Laskowitz DT: Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice. J Neurotrauma 2010; 27: 217-228.